Showing results (101-110 of 130) with videos related to
Sort By:
Pageof 13
Transplantation|October 27, 2005
A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipientsFlavio Vincenti, Robert Mendez, John Curtis, et al.JAMA|June 6, 2023
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical TrialAjit P Limaye, Klemens Budde, Atul Humar, et al.Transplantation|October 28, 2010
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadeAndrew M Posselt, Gregory L Szot, Lynda A Frassetto, et al.The New England Journal of Medicine|January 28, 2016
Belatacept and Long-Term Outcomes in Kidney TransplantationFlavio Vincenti, Lionel Rostaing, Joseph Grinyo, et al.Transplantation|March 5, 2011
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies)Yves Vanrenterghem, Barbara Bresnahan, Josep Campistol, et al.Journal of the American Society of Nephrology : JASN|October 28, 2021
Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b TrialKlemens Budde, Rohini Prashar, Hermann Haller, et al.Transplantation Direct|January 26, 2023
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease PatientsCary M Looney, Aaron Schroeder, Erica Tavares, et al.Clinical Transplantation|February 21, 2018
Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXTSander Florman, Flavio Vincenti, Antoine Durrbach, et al.Clinical Transplantation|May 10, 2005
A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trialHelmut Arbogast, Henning Hückelheim, Helmut Schneeberger, et al.Transplantation|November 16, 2010
Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studiesChristian P Larsen, Josep Grinyó, José Medina-Pestana, et al.Pageof 13